Australia's Anteo Diagnostics has agreed to acquire Belgium-based specialty diagnostics firm DIAsource ImmunoAssays, for around €15.4m (A$23.3m).
Based in Louvain-La-Neuve near Brussels, DIAsource develops, manufactures, markets and distributes clinical diagnostics products in the fields of endocrinology, specifically bone metabolism, fertility, cardiovascular and oncology.
DIAsource also has a fully IVD certified production facility to produce its complete catalogue of antibodies, ELISA and RIA assays.
With a global network of 90 main distributors and 40 OEM partners, DIAsource provides services to customers in around 75 countries across the globe.
The firm reported revenue of €11.9m (A$18.0m) in 2014 and €7.2m (A$10.9m) in the first half of this year.
Anteo Diagnostics has patented technology that will be used to develop, manufacture and commercialise proprietary surface coatings for use in healthcare, life sciences and others.